Patrick J Lenehan
Overview
Explore the profile of Patrick J Lenehan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
271
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lenehan P, Tang A, Watane G, Gujrathi R, Park H, Gosangi B, et al.
J Am Coll Radiol
. 2025 Mar;
22(3):395-404.
PMID: 40044319
Objective: To identify imaging utilization patterns and radiologically evident injuries suggestive of intimate partner violence (IPV). Methods: This retrospective case-control study analyzed historical imaging reports from women reporting physical IPV...
2.
Hall C, Friedmann A, Handorf A, Lenehan P, Sagar P, Bank H, et al.
Pediatrics
. 2024 Oct;
154(5).
PMID: 39444364
A 6-week-old boy is brought to the hospital for fussiness and abdominal distension. He was febrile on presentation and was admitted to the hospital for further evaluation. On subsequent examinations,...
3.
Ghosh P, Niesen M, Pawlowski C, Bandi H, Yoo U, Lenehan P, et al.
iScience
. 2024 Jul;
27(8):110406.
PMID: 39081289
Post-COVID-19 conditions (long COVID) has impacted many individuals, yet risk factors for this condition are poorly understood. This retrospective analysis of 88,943 COVID-19 patients at a multi-state US health system...
4.
Oberstein P, Dias Costa A, Kawaler E, Cardot-Ruffino V, Rahma O, Beri N, et al.
Cancer Immunol Res
. 2024 Jul;
12(9):1221-1235.
PMID: 38990554
Innate inflammation promotes tumor development, although the role of innate inflammatory cytokines in established human tumors is unclear. Herein, we report clinical and translational results from a phase Ib trial...
5.
Ali L, Lenehan P, Cardot-Ruffino V, Dias Costa A, Katz M, Bauer T, et al.
Clin Cancer Res
. 2023 Sep;
30(3):542-553.
PMID: 37733830
Purpose: Pancreatic ductal adenocarcinoma (PDAC) trials have evaluated CTLA-4 and/or PD-(L)1 blockade in patients with advanced disease in which bulky tumor burden and limited time to develop antitumor T cells...
6.
Ali L, Garrido-Castro A, Lenehan P, Bollenrucher N, Stump C, Dougan M, et al.
J Exp Med
. 2023 Aug;
220(9).
PMID: 37615687
No abstract available.
7.
Matson R, Niesen M, Levy E, Opp D, Lenehan P, Donadio G, et al.
Lancet Digit Health
. 2023 Mar;
5(4):e206-e216.
PMID: 36963910
Background: The emergency use authorisation of BNT162b2 (tozinameran; Comirnaty, Pfizer-BioNTech) for children aged 5-17 years has resulted in rapid vaccination in the paediatric population. However, there are few studies of...
8.
Ventre K, Roehle K, Bello E, Bhuiyan A, Biary T, Crowley S, et al.
J Immunol
. 2023 Mar;
210(7):991-1003.
PMID: 36881882
Checkpoint blockade immunotherapy has failed in pancreatic cancer and other poorly responsive tumor types in part due to inadequate T cell priming. Naive T cells can receive costimulation not only...
9.
Niesen M, Matson R, Puranik A, OHoro J, Pawlowski C, Vachon C, et al.
PNAS Nexus
. 2023 Jan;
1(2):pgac042.
PMID: 36713312
As of 2021 November 29, booster vaccination against SARS-CoV-2 infection has been recommended for all individuals aged 18 years and older in the United States. A key reason for this...
10.
Puranik A, Lenehan P, OHoro J, Pawlowski C, Virk A, Swift M, et al.
PNAS Nexus
. 2023 Jan;
1(2):pgac058.
PMID: 36713311
COVID-19 vaccines are effective, but breakthrough infections have been increasingly reported. We conducted a test-negative case-control study to assess the durability of protection against symptomatic infection after vaccination with mRNA-1273....